University Hospitals Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
Location status: Recruiting
Location contact
Bart Swinnen, MD, PhD
CONTACT
Bart Swinnen, MD, PhD
PRINCIPAL_INVESTIGATOR
Loes Laurijssen, MD
SUB_INVESTIGATOR
NCT Number: NCT07485621
The goal of this observational study is to assess whether deep brain stimulation (DBS) contact selection in Parkinson's disease could be informed by subcortical local field potential (LFP) recordings. The main question it aims to answer is:
Aligns stimulation contact selection based on subcortical LFP recordings with clinically optimized contact selection?
Participants will undergo LFP recordings that are part of standard clinical care during their routine hospital visits.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Leuven, Vlaams-Brabant, 3000, Belgium
Location status: Recruiting
Bart Swinnen, MD, PhD
CONTACT
Bart Swinnen, MD, PhD
PRINCIPAL_INVESTIGATOR
Loes Laurijssen, MD
SUB_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From the first LFP recording to the last LFP recording (6 - 9 months)
Alignment between local field potential-based contact selection and the clinically optimized stimulation contact.
Contact information is provided by the study sponsor or research team.
Loes Laurijssen
Other
Assessing the Relation Between Subcortical LFPs and DBS Parameter Selection in Parkinson's Disease - a Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07734181
Basal Ganglia Diseases, Brain Diseases
Arlesheim, Basel-Landschaft, Switzerland
View Trial DetailsNCT07730073
Basal Ganglia Diseases, Brain Diseases
Kâğıthane, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07630545
Basal Ganglia Diseases, Brain Diseases
Adelaide, Australia
View Trial DetailsNCT07284784
Basal Ganglia Diseases, Brain Diseases
Birmingham, Alabama, United States
View Trial Details